Kapur Anil 4
4 · Nurix Therapeutics, Inc. · Filed Oct 16, 2024
Insider Transaction Report
Form 4
Kapur Anil
Director
Transactions
- Award
Director Stock Option (right to buy)
2024-10-15+50,000→ 50,000 totalExercise: $24.87Exp: 2034-10-14→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/36 of the total shares monthly beginning November 15, 2024, until the option is fully vested on October 15, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.